Home › Biogen Idec and Sobi Present New Data from the Phase 3 Study of Their ...
 

Keywords :   


Biogen Idec and Sobi Present New Data from the Phase 3 Study of Their ...

2013-07-04 18:03:24| Biotech - Topix.net

Biogen Idec and Swedish Orphan Biovitrum AB presented new data that support the clinical and safety profile of their long-lasting recombinant factor VIII candidate ELOCTATE* for hemophilia A. Five platform and oral presentations at the XXIV International Society on Thrombosis and Haemostasis Congress in Amsterdam, The Netherlands, highlight the ... (more)

Tags: of their data present

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
08.07Tropical Storm Beryl Public Advisory Number 41
08.07Tropical Storm Beryl Storm Surge Watch/Warning Map
08.07Tropical Storm Beryl Graphics
08.07Tropical Storm Beryl Wind Speed Probabilities Number 41
08.07Tropical Storm Beryl Forecast Advisory Number 41
08.07Durst Group recognized with 13 PRINTING United Pinnacle Awards
08.07Time for the mid-year cattle market assessment
More »